New York, NY -- (SBWIRE) -- 12/13/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC), Nokia Corporation (ADR) (NYSE:NOK), Alpha Natural Resources, Inc (NYSE:ANR), Rite Aid Corporation (NYSE:RAD)
ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) showed a volume of 21.39 million shares by the end of last trade whereas the average volume of the stock remained 1.55 million shares. The stock opened the session at $1.00 but then moved to $1.10. At that price, the stock showed a negative performance of -59.56%. ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors. Immunotherapy is an approach to treat cancer in which a patient’s own immune system is stimulated to target tumor antigens, which are molecular signals that the immune system uses to identify foreign bodies.
Will IMUC Get Buyers Even After The Recent Rally? Find Out Here
Nokia Corporation (ADR) (NYSE:NOK) opened the session at $7.78 and closed the session at $7.71. The stock showed a negative performance of -0.26% in previous trading session. Alpha Natural Resources, Inc. (Alpha) is a supplier and exporter of metallurgical coals for use in the steel-making process and a supplier of thermal coal to electric utilities and manufacturing industries, as well as a exporter of thermal coal. As of December 31, 2012, the Company operated 107 mines and 26 coal preparation plants in Northern and Central Appalachia and the Powder River Basin. The Company operates in two segments:
Has NOK Found The Bottom And Ready To Gain Momentum? Find Out Here
Alpha Natural Resources, Inc (NYSE:ANR) opened the session at $6.84 and closed the session at $6.44. The stock showed a negative performance of -5.99% in previous trading session. The beta of the stock remained 1.63. Nokia Corporation (Nokia) has three operating segments: Devices & Services; NAVTEQ, and Nokia Siemens Networks. Devices & Services is responsible for developing and managing the Company’s portfolio of mobile products, as well as designing and developing services, including applications and content. NAVTEQ is a provider of digital map information and related location-based content and services for mobile navigation devices, automotive navigation systems, Internet-based mapping applications,
Why Should Investors Buy ANR After the Recent Fall? Just Go Here and Find Out
Rite Aid Corporation (NYSE:RAD) the stock advanced 0.72% and finished the session at $5.59. Traded with volume of 18.93 million shares in the prior session and the average volume of the stock remained 25.59 million shares. The beta of the stock remained 2.42. Rite Aid Corporation is a retail drugstore chain in the United States. As of March 3, 2013, it operated 4,623 stores in 31 states across the country and in the District of Columbia. In the Company’s stores, it sells prescription drugs and a range of other merchandise, which it calls front end products. During the fiscal year ended March 3, 2013 (fiscal 2013), prescription drug sales accounted for 67.6% of its total sales.
Will RAD Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)